Cargando…

Long Pentraxin 3: Experimental and Clinical Relevance in Cardiovascular Diseases

Pentraxin 3 (PTX3) is an essential component of the humoral arm of innate immunity and belongs, together with the C-reactive protein (CRP) and other acute phase proteins, to the pentraxins' superfamily: soluble, multifunctional, pattern recognition proteins. Pentraxins share a common C-terminal...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonacina, Fabrizia, Baragetti, Andrea, Catapano, Alberico Luigi, Norata, Giuseppe Danilo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3649691/
https://www.ncbi.nlm.nih.gov/pubmed/23690668
http://dx.doi.org/10.1155/2013/725102
_version_ 1782269018532478976
author Bonacina, Fabrizia
Baragetti, Andrea
Catapano, Alberico Luigi
Norata, Giuseppe Danilo
author_facet Bonacina, Fabrizia
Baragetti, Andrea
Catapano, Alberico Luigi
Norata, Giuseppe Danilo
author_sort Bonacina, Fabrizia
collection PubMed
description Pentraxin 3 (PTX3) is an essential component of the humoral arm of innate immunity and belongs, together with the C-reactive protein (CRP) and other acute phase proteins, to the pentraxins' superfamily: soluble, multifunctional, pattern recognition proteins. Pentraxins share a common C-terminal pentraxin domain, which in the case of PTX3 is coupled to an unrelated long N-terminal domain. PTX3 in humans, like CRP, correlates with surrogate markers of atherosclerosis and is independently associated with the risk of developing vascular events. Studies addressing the potential physiopathological role of CRP in the cardiovascular system were so far inconclusive and have been limited by the fact that the sequence and regulation have not been conserved during evolution between mouse and man. On the contrary, the conservation of sequence, gene organization, and regulation of PTX3 supports the translation of animal model findings in humans. While PTX3 deficiency is associated with increased inflammation, cardiac damage, and atherosclerosis, the overexpression limits carotid restenosis after angioplasty. These observations point to a cardiovascular protective effect of PTX3 potentially associated with the ability of tuning inflammation and favor the hypothesis that the increased levels of PTX3 in subjects with cardiovascular diseases may reflect a protective physiological mechanism, which correlates with the immunoinflammatory response observed in several cardiovascular disorders.
format Online
Article
Text
id pubmed-3649691
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-36496912013-05-20 Long Pentraxin 3: Experimental and Clinical Relevance in Cardiovascular Diseases Bonacina, Fabrizia Baragetti, Andrea Catapano, Alberico Luigi Norata, Giuseppe Danilo Mediators Inflamm Review Article Pentraxin 3 (PTX3) is an essential component of the humoral arm of innate immunity and belongs, together with the C-reactive protein (CRP) and other acute phase proteins, to the pentraxins' superfamily: soluble, multifunctional, pattern recognition proteins. Pentraxins share a common C-terminal pentraxin domain, which in the case of PTX3 is coupled to an unrelated long N-terminal domain. PTX3 in humans, like CRP, correlates with surrogate markers of atherosclerosis and is independently associated with the risk of developing vascular events. Studies addressing the potential physiopathological role of CRP in the cardiovascular system were so far inconclusive and have been limited by the fact that the sequence and regulation have not been conserved during evolution between mouse and man. On the contrary, the conservation of sequence, gene organization, and regulation of PTX3 supports the translation of animal model findings in humans. While PTX3 deficiency is associated with increased inflammation, cardiac damage, and atherosclerosis, the overexpression limits carotid restenosis after angioplasty. These observations point to a cardiovascular protective effect of PTX3 potentially associated with the ability of tuning inflammation and favor the hypothesis that the increased levels of PTX3 in subjects with cardiovascular diseases may reflect a protective physiological mechanism, which correlates with the immunoinflammatory response observed in several cardiovascular disorders. Hindawi Publishing Corporation 2013 2013-04-07 /pmc/articles/PMC3649691/ /pubmed/23690668 http://dx.doi.org/10.1155/2013/725102 Text en Copyright © 2013 Fabrizia Bonacina et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Bonacina, Fabrizia
Baragetti, Andrea
Catapano, Alberico Luigi
Norata, Giuseppe Danilo
Long Pentraxin 3: Experimental and Clinical Relevance in Cardiovascular Diseases
title Long Pentraxin 3: Experimental and Clinical Relevance in Cardiovascular Diseases
title_full Long Pentraxin 3: Experimental and Clinical Relevance in Cardiovascular Diseases
title_fullStr Long Pentraxin 3: Experimental and Clinical Relevance in Cardiovascular Diseases
title_full_unstemmed Long Pentraxin 3: Experimental and Clinical Relevance in Cardiovascular Diseases
title_short Long Pentraxin 3: Experimental and Clinical Relevance in Cardiovascular Diseases
title_sort long pentraxin 3: experimental and clinical relevance in cardiovascular diseases
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3649691/
https://www.ncbi.nlm.nih.gov/pubmed/23690668
http://dx.doi.org/10.1155/2013/725102
work_keys_str_mv AT bonacinafabrizia longpentraxin3experimentalandclinicalrelevanceincardiovasculardiseases
AT baragettiandrea longpentraxin3experimentalandclinicalrelevanceincardiovasculardiseases
AT catapanoalbericoluigi longpentraxin3experimentalandclinicalrelevanceincardiovasculardiseases
AT noratagiuseppedanilo longpentraxin3experimentalandclinicalrelevanceincardiovasculardiseases